Covista Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

CVSA$116.50+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Cash Flows

(in thousands)


· · Nine Months Ended
· · March 31,
· · 2026 · · 2025
Operating activities:
Net income	$179,845	$182,853
Loss (income) from discontinued operations	15,370	(4,638)
Income from continuing operations	195,215	178,215
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	31,103	31,181
Amortization and impairments to operating lease assets	21,004	25,330
Depreciation	32,627	30,267
Amortization of acquired intangible assets	8,415	8,415
Amortization and write-off of debt discount and issuance costs	6,961	4,995
Provision for bad debts	48,853	46,854
Deferred income taxes	65,318	19,994
Loss on disposals and impairments of property and equipment	605	2,522
Gain on investments	(561)	(268)
Changes in assets and liabilities:
Accounts and financing receivables	(76,271)	(80,613)
Prepaid expenses and other current assets	(896)	5,727
Cloud computing implementation assets	(10,087)	(21,959)
Accounts payable	(12,607)	(9,978)
Accrued payroll and benefits	(1,136)	1,406
Accrued liabilities	(10,168)	(10,449)
Deferred revenue	66,322	66,081
Operating lease liabilities	(15,395)	(17,839)
Other assets and liabilities	(2,888)	(6,068)
Net cash provided by operating activities-continuing operations	346,414	273,813
Net cash provided by operating activities-discontinued operations	45	4,394
Net cash provided by operating activities	346,459	278,207
Investing activities:
Capital expenditures	(50,882)	(31,337)
Proceeds from sales of marketable securities	2,314	3,120
Purchases of marketable securities	(2,313)	(2,048)
Payment for investment in business	(5,000)	—
Net cash used in investing activities	(55,881)	(30,265)
Financing activities:
Proceeds from exercise of stock options	131	10,008
Employee taxes paid on withholding shares	(42,074)	(12,457)
Proceeds from stock issued under Colleague Stock Purchase Plan	1,305	922
Repurchases of common stock for treasury	(239,866)	(146,436)
Borrowings under long-term debt obligations	844,450	9,873
Repayments under long-term debt obligations	(895,283)	(109,873)
Payment of debt issuance and extinguishment costs	(11,566)	—
Net cash used in financing activities	(342,903)	(247,963)
Net decrease in cash, cash equivalents and restricted cash	(52,325)	(21)
Cash, cash equivalents and restricted cash at beginning of period	201,164	221,202
Cash, cash equivalents and restricted cash at end of period	$148,839	$221,181
Non-cash investing and financing activities:
Accrued capital expenditures	$12,417	$12,410
Accrued liability for repurchases of common stock	$—	$4,879
Accrued excise tax on share repurchases	$1,739	$1,055
Accrued debt issuance and extinguishment costs	$421	$—

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.